A. A licensee shall develop, implement and comply with written policies and procedures for the monitoring of a clients alcohol and/or drug use during treatment through alcohol and drug testing to include:
1. A method for ensuring the protection of the clients dignity and privacy while minimizing opportunity for falsification during collection,
2. Documentation that the client is informed how drug specimens are collected and client responsibility to provide specimens when asked,
3. For positive screens which may result in the clients’ exclusion from treatment or consequences related to the positive screen, results shall be confirmed by Gas Chromatography Mass Spectophotometry (GCMS) or a similar test which isolates the active metabolite responsible for positive screen, and
4. Procedures for utilizing results in the client treatment that reflect a therapeutic constructive approach.
|
Review policy and procedure manual for elements of R03-607A 1-4.
2. Review client file for a signed form or statement that they were informed of the collection procedures at admission. |
|
